Posted on 11/1/17
B&G Foods (BGS) Q3 2017 Results - Earnings Call Transcript
B&G Foods, Inc. (NYSE:BGS)Q3 2017 Earnings CallOctober 31, 2017 4:30 pm ETExecutivesBruce C. Wacha - B&G Foods, Inc.Robert C. Cantwell - B&G Foods, Inc.AnalystsRobert Moskow - . . .
Posted on 11/1/17
Pfizer (PFE) Q3 2017 Results - Earnings Call Transcript
Pfizer Inc. (NYSE:PFE)Q3 2017 Earnings CallOctober 31, 2017 10:00 am ETExecutivesCharles E. Triano - Pfizer Inc.Ian C. Read - Pfizer Inc.Frank A. D'Amelio - Pfizer Inc.Albert . . .
Posted on 11/1/17
If Celgene Buys This Biotech, Investors Should Win Big Time
Celgene (NASDAQ:CELG) has fallen on hard times of late -- or its stock has, at least. At the beginning of October, the biotech's share price was . . .
Posted on 11/1/17
Soligenix Prices $5,115,000 Concurrent Registered Direct Offering
Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced . . .
Posted on 10/31/17
Dividend Aristocrats In Focus Part 27: Johnson & Johnson
Every year, we review each of the 51 Dividend Aristocrats, a group of companies in the S&P 500 Index, with 25+ consecutive years of dividend increases. . . .
Posted on 11/9/17
Interview with Steve Wray, CEO of CloudMine - Part III
Brought to you by Newmark Knight Frank
Posted on 11/7/17
Interview with Steve Wray, CEO of CloudMine - Part II
Brought to you by Newmark Knight Frank
Posted on 11/1/17
Interview with Steve Wray, CEO of CloudMine - Part I
Brought to you by Newmark Knight Frank
Posted on 10/31/17
Celgene (CELG) Presents At ECTRIMS 2017 IR Event - Slideshow
The following slide deck was published by Celgene Corporation in conjunction with this event. 154READ FULL ARTICLE HERE
Posted on 10/31/17
2 Top Pharma Stocks on Sale This Week
Like most investors, I love a good bargain. So when the top pharma stocks Celgene Corporation (NASDAQ:CELG) and GlaxoSmithKline plc (NYSE:GSK) both crashed last week, it . . .
Posted on 10/31/17
Celgene Corporation Has "Optionality and Opportunity"
Celgene (NASDAQ:CELG) got crushed after announcing third-quarter earnings, saying revenue would come in at the bottom of previous guidance, and lowering its 2020 guidance. All things . . .
Posted on 10/31/17
Philadelphia 100 Recognizes Medical Guardian for Business Growth
PHILADELPHIA--(BUSINESS WIRE)--Medical Guardian™ was recognized by Philadelphia 100, one of Greater Philadelphia’s most prestigious awards. The coveted annual list honors the fastest growing privately held companies . . .
Posted on 10/30/17
Lannett And Celgene Enter Into Settlement And License Agreement Related To Thalomid
Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into a settlement and license agreement with Celgene Corporation that resolves patent infringement litigation in . . .
Posted on 10/30/17
Merck & Co. (MRK) Q3 2017 Results - Earnings Call Transcript
Merck & Co., Inc. (NYSE:MRK)Q3 2017 Earnings CallOctober 27, 2017 8:00 am ETExecutivesTeri Loxam - Merck & Co., Inc.Kenneth C. Frazier - Merck & Co., Inc.Robert . . .
Posted on 10/30/17
Why Celgene Got Pummeled
Revlimid. Source: drugs.comCelgene (CELG) reported Q3 earnings Thursday and it did not go well. Investors did not like what they heard and pummeled CELG, driving the . . .
Posted on 10/30/17
Stop Panicking About Celgene
Judging by the market reaction to Celgene's (NASDAQ:CELG) third-quarter results, you'd think one of the Four Horsemen of the Apocalypse just rode down Wall Street. Or . . .
Posted on 10/30/17
Celgene At $100: Buy, Sell, or Hold?
It's been a rotten couple of weeks to be a shareholder of Celgene (NASDAQ:CELG). The biotech giant's shares have been in near-freefall after they reached an . . .
Posted on 11/3/17
Castle Creek Pharmaceuticals Receives Partners in Progress Award from Debra of America
Castle Creek Pharmaceuticals (CCP), a global company dedicated to delivering transformative therapies to patients with orphan dermatologic and other underserved conditions, today announced that the company . . .
Posted on 10/27/17
Safeguard Scientifics, Inc. 2017 Q3 - Results - Earnings Call Slides
The following slide deck was published by Safeguard Scientifics, Inc. in conjunction with their 2017 Q3 earnings call. 114READ FULL ARTICLE HERE
Posted on 10/27/17
Celgene: Sell-Off Is Overdone
It's never fun when you see one of your holdings sell off ~20% or so in a single trading day. This typically means that something has . . .
Posted on 10/27/17
Celgene Crashes: A Reassessment
IntroductionNow that Celgene (CELG) has plunged in short order from an all-time high above $145 to below $100 as I write this intra-day Thursday, it's time . . .
Posted on 10/27/17
Was Celgene’s Third Quarter Really Crash-Worthy?
On the heels of reporting a disappointing late-stage trial failure, Celgene Corp.(NASDAQ:CELG) issued a poor third-quarter financial report that's stoking investors' fears. Has the biotech lost . . .
Posted on 10/27/17
Idera Pharmaceuticals Prices Public Offering of Common Stock
CAMBRIDGE, Mass. and EXTON, Pa. , Oct. 26, 2017 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) announced the pricing of its underwritten public offering of 33,333,334 . . .
Posted on 11/1/17
Proscia Selected as Entrepreneurial Company to Present at 2017 PACT Capital Conference
Proscia Inc., a data solutions provider for digital pathology, announced today that the company was selected as one of the 45 Entrepreneurial Companies to present at . . .
Posted on 10/26/17
West Announces Third-Quarter 2017 Results
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2017, updated financial guidance for the full-year 2017, introduced sales . . .

